Julie learned she was allergic to peanuts at two years old. After more than 20 allergic reactions to peanut while growing up, she discovered a peanut allergy clinical trial at Virginia Mason.

Though the results of the clinical trial have not yet been released, Julie personally had a good result. While trace amounts of peanut protein used to send her into anaphylactic shock, she can now tolerate peanut protein without medication. 

The study aimed to test whether people could become desensitized to peanuts by taking small amounts of peanut powder daily. In addition, BRI’s allergy researcher, Erik Wambre, PhD and his team are analyzing blood samples from this clinical trial in order to learn more about the cells that lead to allergic reaction and how they respond to immunotherapy.

Learn more…